|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Immix Biopharma, Inc. (IMMX) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
7,581,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Immix Biopharma is a clinical-stage biopharmaceutical company engaged in the development of a class of Tissue-Specific Therapeutics (TSTx)™ in oncology and inflammation. Co.'s primary asset, IMX-110, is for the treatment of solid tumors. IMX-110 is a negatively-charged TSTx that simultaneously disables resistance pathways with a poly-kinase inhibitor and induces tumor cell death with an apoptosis inducer, utilizing Co.'s TME Normalization™ Technology, delivered deep into the tumor micro-environment (TME). Co.'s TME Normalization™ Technology allows its drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
56,000 |
201,000 |
211,400 |
| Total Buy Value |
$0 |
$266,919 |
$654,971 |
$665,084 |
| Total People Bought |
0 |
1 |
5 |
7 |
| Total Buy Transactions |
0 |
2 |
13 |
15 |
| Total Shares Sold |
0 |
0 |
0 |
200 |
| Total Sell Value |
$0 |
$0 |
$0 |
$550 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
1 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Rachman Ilya M |
CEO and Chairman |
• • – |
2024-05-14 |
4 |
B |
$2.25 |
$9,660 |
D/D |
4,300 |
912,000 |
2.81 |
- |
|
| Morris Gabriel S |
CFO |
• • – |
2024-05-14 |
4 |
B |
$2.23 |
$10,042 |
D/D |
4,500 |
85,816 |
2.81 |
- |
|
| Hsu Jason |
Director |
– • – |
2023-12-11 |
4 |
B |
$4.67 |
$144,894 |
D/D |
31,000 |
813,000 |
2.39 |
- |
|
| Hsu Jason |
Director |
– • – |
2023-12-08 |
4 |
B |
$4.88 |
$122,025 |
D/D |
25,000 |
782,000 |
2.39 |
- |
|
| Hsu Jason |
Director |
– • – |
2023-09-15 |
4 |
B |
$2.49 |
$17,396 |
D/D |
7,000 |
757,000 |
2.39 |
- |
|
| Hsu Jason |
Director |
– • – |
2023-09-14 |
4 |
B |
$2.58 |
$25,772 |
D/D |
10,000 |
750,000 |
2.39 |
- |
|
| Ng Carey |
Director |
– • – |
2023-09-14 |
4 |
B |
$2.58 |
$25,760 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
| Hsu Jason |
Director |
– • – |
2023-09-12 |
4 |
B |
$2.83 |
$84,864 |
D/D |
30,000 |
740,000 |
2.39 |
- |
|
| Adams Helen C. |
Director |
– • – |
2023-09-12 |
4 |
B |
$2.96 |
$38,492 |
D/D |
13,000 |
13,000 |
2.39 |
- |
|
| Hsu Jason |
Director |
– • – |
2023-09-11 |
4 |
B |
$2.89 |
$72,280 |
D/D |
25,000 |
710,000 |
2.39 |
- |
|
| Hsu Jason |
Director |
– • – |
2023-09-08 |
4 |
B |
$2.53 |
$25,317 |
D/D |
10,000 |
685,000 |
2.39 |
- |
|
| Buchan Melissa Jane |
Director |
– • – |
2023-09-07 |
4 |
B |
$2.46 |
$49,226 |
D/D |
20,000 |
20,000 |
2.39 |
- |
|
| Marquet Magda |
Director |
– • – |
2023-09-06 |
4 |
B |
$2.47 |
$22,213 |
I/I |
9,000 |
20,000 |
2.1 |
- |
|
| Marquet Magda |
Director |
– • – |
2023-09-05 |
4 |
B |
$2.47 |
$24,722 |
I/I |
10,000 |
11,000 |
2.1 |
- |
|
| Marquet Magda |
Director |
– • – |
2023-08-31 |
4 |
B |
$2.01 |
$2,010 |
I/I |
1,000 |
1,000 |
2.02 |
- |
|
| Chudnovsky Yekaterina |
Director |
– • • |
2023-08-22 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,241,076 |
|
- |
|
| Rachman Ilya M |
CEO and Chairman |
• • – |
2022-11-14 |
4 |
B |
$0.95 |
$5,225 |
D/D |
5,200 |
907,700 |
2.81 |
- |
|
| Morris Gabriel S |
CFO |
• • – |
2022-11-14 |
4 |
B |
$0.94 |
$4,888 |
D/D |
5,200 |
81,316 |
2.73 |
- |
|
| Senn Sean |
10% Owner |
– – • |
2022-07-14 |
4 |
S |
$2.75 |
$550 |
D/D |
(200) |
899,800 |
|
- |
|
| Torchilin Vladimir P |
Scientific Co-Founder |
• – – |
2021-12-20 |
4 |
B |
$5.00 |
$15,000 |
D/D |
3,000 |
905,200 |
2.74 |
- |
|
| Morris Gabriel S |
Chief Financial Officer |
• • – |
2021-12-20 |
4 |
B |
$5.00 |
$10,000 |
D/D |
2,000 |
76,116 |
2.81 |
- |
|
| Morris Gabriel S |
Chief Financial Officer |
• • – |
2021-12-20 |
4 |
OE |
$0.85 |
$209,698 |
I/I |
246,703 |
246,703 |
|
- |
|
| Morris Gabriel S |
Chief Financial Officer |
• • – |
2021-12-20 |
4 |
OE |
$0.85 |
$62,999 |
D/D |
74,116 |
74,116 |
|
- |
|
| Hsu Jason |
Director |
– • – |
2021-12-20 |
4 |
B |
$5.00 |
$250,000 |
I/I |
50,000 |
50,000 |
2.1 |
- |
|
| Hsu Jason |
Director |
– • – |
2021-12-20 |
4 |
OE |
$0.85 |
$3,328,526 |
I/I |
3,915,913 |
3,915,913 |
|
- |
|
33 Records found
|
|
Page 1 of 2 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
